Chenghao Jin
Jiangxi Provincial People's Hopital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chenghao Jin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:03 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06569108 · Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without InhibitorsSuzhou Alphamab Co., Ltd. · active not recruiting · Hemophilia A Without Inhibitor, Hemophilia B Without Inhibitor · principal investigator
- Ph3NCT06312475 · Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With InhibitorsSuzhou Alphamab Co., Ltd. · active not recruiting · Hemophilia A With Inhibitor, Hemophilia B With Inhibitor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:03 UTC. The ranking covers the 200 most relevant of 177 PubMed records, and a shared surname and initials can bring in a namesake. All 177 on PubMed
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma.Sci Transl Med · 2018505 citationsRCR 14.5
- 249 citationsRCR 9.1
- Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.Lancet Gastroenterol Hepatol · 2021229 citationsRCR 12.7
- Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience.Radiology · 2005211 citationsRCR 6.4
- Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial.Lancet Haematol · 2019210 citationsRCR 7.0
- Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience.Ultrasound Med Biol · 2004191 citationsRCR 6.0
- Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.Radiology · 2005189 citationsRCR 6.1
- Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma.Ann Surg Oncol · 2004186 citationsRCR 5.6
- 144 citationsRCR 5.7
- Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.Lancet Neurol · 2021137 citationsRCR 10.5